NCT00283179View on ClinicalTrials.gov

Aripiprazole in the Treatment of Acutely Relapsed Patients With Schizophrenia

PHASE3CompletedINTERVENTIONAL
Enrollment

83

Participants

Timeline

Start Date

March 31, 2004

Study Completion Date

December 31, 2004

Conditions
SchizophreniaSchizoaffective Disorder
Interventions
DRUG

Aripiprazole

DRUG

Risperidone

Trial Locations (1)

100

National Taiwan University Hospital, Taipei

All Listed Sponsors
lead

Taiwan Otsuka Pharm. Co., Ltd

INDUSTRY

NCT00283179 - Aripiprazole in the Treatment of Acutely Relapsed Patients With Schizophrenia | Biotech Hunter | Biotech Hunter